NEW YORK ( TheStreet) -- CHANGE IN RATINGS Bed Bath & Beyond ( BBBY) was upgraded from Neutral to Outperform at Credit Suisse. $91 price target. Cost Plus acquisition should help boost growth. Best Buy ( BBY) downgraded from Outperform to Neutral at Credit Suisse. Company is facing multiple operating distractions. $20 price target. The Buckle ( BKE) was initiated with an Underperform rating at Bank of America Merrill Lynch. $42 price target. Slowing growth should drive underperformance. Meta Financial Group ( CASH) was upgraded to Buy at TheStreet Ratings. Clear Channel Communications ( CCO) was downgraded to Sell at TheStreet Ratings. C.H. Robinson Worldwide ( CHRW) was rated new Perform at Oppenheimer. Do not anticipate the market bolstering its trading multiple. Heska ( HSKA) was upgraded to Buy at TheStreet Ratings. Incyte ( INCY) was upgraded to Buy from Neutral at Goldman Sachs. $29 price target. Strong Jakafi launch and pipeline has upside potential. JP Morgan ( JPM) was downgraded to Market Perform at FBR Capital Markets. $37 price target. Credit derivative losses are cutting into earnings. Landstar System ( LSTR) was rated new Outperform at Oppenheimer said. $66 price target. Revenue and gross profit growth in the double digits. Steinway Musical Instruments ( LVB) was upgraded to Buy at TheStreet Ratings. Macerich ( MAC) was downgraded to Hold from Buy at Jefferies. Still like the story but upside now seems limited. Myriad Genetics ( MYGN) was initiated with a Neutral rating at Bank of America Merrill Lynch. $28 price target. Shares appear fairly valued given uncertainties. PSS World Medical ( PSSI) was downgraded from Outperform to Neutral at Robert Baird. $21 price target. Company missed expectations again and lacks near-term catalysts. Rexnord ( RXN) was initiated with a Neutral rating at Goldman Sachs. Valuation call, based on a $23 price target. AT&T ( T) was upgraded to Outperform at Credit Suisse said. Spending discipline appears to be improving across the industry. $36.50 price target. Verizon ( VZ) was upgraded to Outperform at Credit Suisse. $45 price target. Estimates also boosted, given higher expected wireless margins. Zumiez ( ZUMZ) was initiated with a Buy rating, Bank of America Merrill Lynch said. $44 price target. e-commerce, young stores, and share gains should fuel growth. Wynn Resorts ( WYNN) was downgraded to Hold at TheStreet Ratings.
Twitter and become a fan on Facebook.
STOCK COMMENTS / EPS CHANGESApple ( AAPL) estimates were cut through 2013 at Credit Suisse. Expect slower U.S. smartphone growth. Outperform rating and $750 price target. Sotheby's ( BID) estimates, target cut at Craig-Hallum. Shares of BID now seen reaching $40, according to Craig-Hallum. Estimates also reduced, as the company is realizing lower margins. Buy rating. Express Scripts ( ESRX) estimates lowered through 2013 at Citigroup. Strong results, but tweak EPS for taxes and shares. Buy rating and $66 price target. Federal Realty Investment Trust ( FRT) numbers raised at Jefferies. Shares of FRT now seen reaching $103, Jefferies said. Estimates also raised on operating results that should continue to improve. Hold rating. Joy Global ( JOY) target lowered at Jefferies. Shares of JOY now seen reaching $74, Jefferies said. Lower aftermarket sales. Hold rating. JP Morgan ( JPM) estimates lowered through 2012 on current trading loss estimate at Citigroup. Buy rating and $54 price target. Molycorp ( MCP) estimates, target cut at JP Morgan. Shares of MCP now seen reaching $23, according to JP Morgan. Estimates also reduced, given lower expected rare earth prices. Neutral rating. Qualcomm ( QCOM) estimates were cut through 2013 at Credit Suisse. Expect fewer smartphone subsidies, which could cut into U.S. sales. Outperform rating and $75 price target. Research in Motion ( RIMM) estimates were reduced through 2014 at Credit Suisse. Expect slower domestic smartphone growth. Neutral rating and $14.50 price target. Roundy's ( RNDY) numbers lowered at Jefferies. Shares of RNDY now seen reaching $13, Jefferies said. Estimates also lowered on a tough year for the food-at-home vertical. Buy rating. Safeway ( SWY) estimates were cut through 2014 at Morgan Stanley. Don't expect sales volumes to improve in the near term. Equal-weight rating. >To submit a news tip, email: firstname.lastname@example.org.
READERS ALSO LIKE:
Twitter and become a fan on Facebook.